{"id":"W4401213085","doi":"10.1111/apt.18158","title":"Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study","year":2024,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Western University","funders":"Janssen Biotech; Gilead Sciences; AstraZeneca; Galápagos; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Ulcerative colitis; Open label; Janus kinase inhibitor; Interim analysis; Colitis; Interim; Internal medicine; Surgery; Gastroenterology; Clinical trial; Janus kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01061569,0.001136647,0.002292517,0.0005477677,0.0007337949,0.001534535,0.0006633704,0.001122748,0.003821769],"category_scores_gemma":[0.004983478,0.0003661127,0.003827782,0.0005167887,0.0006067866,0.001206833,0.0007606177,0.00208561,0.0007946766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000598614,"about_ca_system_score_gemma":0.0009784381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003667657,"about_ca_topic_score_gemma":0.0006546557,"domain_scores_codex":[0.9974622,0.001051563,0.0002073788,0.0003678059,0.000410858,0.0005002446],"domain_scores_gemma":[0.9939258,0.001354204,0.002202017,0.00104475,0.0006839582,0.0007892051],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7983043,0.006422058,0.1089924,0.0008074543,0.006528668,0.0004191188,0.0002711054,0.002469595,0.01101275,0.0002073734,0.00461026,0.05995509],"study_design_scores_gemma":[0.08316608,0.3107551,0.5681036,0.0002571287,0.01321563,0.001034466,0.0002434885,0.003701933,0.008155903,0.0008781644,0.01030222,0.0001862494],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863534,0.002881556,0.001203269,0.0002462832,0.00008457574,0.0008763897,0.006032022,0.0001095032,0.002213044],"genre_scores_gemma":[0.9814641,0.0004369564,0.001090198,0.000467717,0.0001220991,0.001397258,0.01268033,0.00003447504,0.002306902],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01061569,"threshold_uncertainty_score":0.05614179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05138483360915472,"score_gpt":0.382088891262624,"score_spread":0.3307040576534693,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}